Efficacy and safety of HLX07 monotherapy in advanced cutaneous squamous cell carcinoma: An open-label, multicentre phase II study

被引：1

作者：

Li, C. ^{[1
]}

Zhu, D. ^{[2
]}

Fan, Z. ^{[3
]}

Chen, Y. ^{[4
,5
]}

Li, Y. ^{[6
]}

Ji, M. ^{[7
]}

Duan, P. ^{[8
]}

Su, J. ^{[9
]}

Yang, J. ^{[10
]}

Tang, Y. ^{[11
]}

Zhang, M. ^{[12
]}

Wang, S. ^{[13
]}

Yu, G. ^{[14
]}

Huang, Y. ^{[15
]}

Chen, R. ^{[16
]}

Hu, X. ^{[17
]}

Wang, L. ^{[17
]}

Wang, Q. ^{[17
]}

Zhu, J. ^{[17
]}

机构：

[1] Southern Med Univ, Nanfang Hosp, Dept Dermatol, Guangzhou, Peoples R China

[2] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Rare Oncol, Jinan, Peoples R China

[3] Beijing Canc Hosp, Dept Bone & Soft Tissue Oncol, Beijing, Peoples R China

[4] Fudan Univ, Dept Bone & Soft Tissue Surg, Shanghai Canc Ctr, Shanghai, Peoples R China

[5] Fujian Canc Hosp, Immunotherapy Ctr, Fuzhou, Peoples R China

[6] Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang, Jiangxi, Peoples R China

[7] Xiamen Med Coll, Dept Dermatol, Affiliated Hosp 2, Xiamen, Peoples R China

[8] Chengdu Integrated TCM & Western Med Hosp, Dept Oncol, Chengdu, Peoples R China

[9] Cent South Univ, Dept Dermatol, Xiangya Hosp, Changsha, Peoples R China

[10] Tianjin Canc Inst & Hosp, Dept Bone & Soft Tissue Oncol, Tianjin, Peoples R China

[11] Kunming Med Univ, Dept Dermatol, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China

[12] Anhui Med Univ, Dept Oncol, Hosp 2, Hefei, Peoples R China

[13] Sun Yat Sen Univ, Dept Head & Neck Oncol, Affiliated Hosp 5, Zhuhai, Peoples R China

[14] Jiangmen Cent Hosp, Dept Oncol, Jiangmen, Peoples R China

[15] Maoming Peoples Hosp, Dept Oncol, Maoming, Peoples R China

[16] Southern Med Univ, Dept Dermatol, Dermatol Hosp, Guangzhou, Peoples R China

[17] Shanghai Henlius Biotech Inc, Global Prod Dev, Shanghai, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.10.221

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

86P

引用

页码：S1500 / S1500

页数：1